You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Jeff Fitzgerald has joined Expression Analysis as director of business development.
Expression Analysis has hired Jeff Fitzgerald as director of business development. Fitzgerald has more than ten years of sales and support experience with Affymetrix and RainDance Technologies.
Expression Analysis has appointed Jeff Fitzgerald as director of business development.
This story was originally published Aug. 8.
Expression Analysis is now a certified service provider of Agilent's SureSelect target enrichment kit, the companies said this week.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today announced that Expression Analysis is now a certified service provider for its SureSelect Target Enrichment System for next-generation sequencing.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
PacBio is recommending EA as its North American service provider for the pharmaceutical market.
The deal gives Quintiles access to PGT’s genomic data-analysis technology, and is in line with Quintiles' ongoing efforts to expand its pharmacogenomics research capabilities.
The companies' first project will be a renal cancer clinical trial for an undisclosed Quintiles client. The partners aim to identify genetic markers that are predictive of adverse events and efficacy.
The firms will jointly identify opportunities to apply large-scale genomic analyses to test clinical hypotheses and correlate biomarkers of disease prognosis and drug responsiveness.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.